The application for marketing authorisation is sent to the Director General of the Agence nationale de sécurité du médicament et des produits de santé. It must state :
1° The name and address of the future marketing authorisation holder and, where applicable, those of the company exploiting the proprietary medicinal product, as well as those of the manufacturer where neither the future marketing authorisation holder nor the company exploiting the proprietary medicinal product manufactures ;
2° The name of the medicinal product;
3° The complete composition of the medicinal product, either per dosage unit or per unit of weight or volume, including the common names of its constituents.
The application is accompanied by a draft summary of product characteristics, the presentation and content of which are laid down in accordance with article 11 of Directive 2001/83/EC of 6 November 2001 by order of the Minister for Health, issued on a proposal from the Director General of the Agency.